target group
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukemia, Pediatric Trial (CareMeds Intervention, Usual Care Group)
Not yet recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- CareMeds Intervention
- Usual Care Group
- (no location specified)
Oct 12, 2023
Autism Spectrum Disorder, Autism Trial in Messina (ApisMela protocol, "Unstuck and on Target" protocol)
Recruiting
- Autism Spectrum Disorder
- Autism
- ApisMela protocol
- "Unstuck and on Target" protocol
-
Messina, ItalyInstitute for Biomedical Research and Innovation (IRIB) - Nation
Jul 27, 2023
COPD Trial in Denmark (Spirometry)
Recruiting
- COPD
- Spirometry
-
Copenhagen, Denmark
- +10 more
Dec 7, 2022
Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated
Active, not recruiting
- Streptococcal Sepsis
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center (primary center co
Nov 8, 2023
Myocardial Infarction, Coronary Artery Bypass, Percutaneous Coronary Intervention Trial in Springfield, Detroit (RPE (usual
Not yet recruiting
- Myocardial Infarction
- +4 more
- RPE (usual care)
- GXT+THHR (intervention)
-
Springfield, Massachusetts
- +1 more
Jun 22, 2023
Oxygenation Parameters in Patients Undergoing Rhinoplasty Under
Recruiting
- Anesthesia; Functional
- target controlled infusion (TCI) group
-
Düzce, TurkeyGizem Demir Şenoğlu
Mar 2, 2023
Omitting Clinical Target Volume of Unresectable Stage III
Completed
- Stage III Non-small-cell Lung Cancer
- The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.
- (no location specified)
Aug 29, 2022
PROSPECT - Profiling of Resistance Patterns & Oncogenic
Recruiting
- Lung Cancer
- Cancer of Thorax
- Group Specific Aim 1
- +5 more
-
Houston, TexasM D Anderson Caner Center
Jun 29, 2022
Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:
Not yet recruiting
- Aortic Valve Disease
- Apixaban 5 MG Oral Tablet
- warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
-
Paris, FranceService de Cardiologie Hôpital Lariboisière
Jan 24, 2023
Autism Spectrum Disorder Trial (HEARTS classes, Online discussion group)
Not yet recruiting
- Autism Spectrum Disorder
- HEARTS classes
- Online discussion group
- (no location specified)
Nov 1, 2022
Blood Pressure Control Target in Diabetes Trial in Shanghai (Treatment strategy regarding different systolic BP goals)
Active, not recruiting
- Blood Pressure Control Target in Diabetes
- Treatment strategy regarding different systolic BP goals
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiaotong University School of Medicine
Jan 4, 2022
Moderate to Severe Calcified Coronary Artery Stenosis Trial (T-wave coronary lithotripsy catheter system)
Not yet recruiting
- Moderate to Severe Calcified Coronary Artery Stenosis
- T-wave coronary lithotripsy catheter system
- (no location specified)
Dec 21, 2022
Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous
Not yet recruiting
- Recurrent Glioblastoma
- Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 10, 2022
Sedative, Hypnotic, or Anxiolytic Withdrawal, Airway Control Trial in Beijing (Respiratory Humidification Treatment Device,
Recruiting
- Sedative, Hypnotic, or Anxiolytic Withdrawal
- Airway Control
- Respiratory Humidification Treatment Device, AIRVO 2 PT101AZ, Fisher & Paykel Healthcare, Inc.
- +11 more
-
Beijing, Beijing, ChinaPeking University Hospital of Stomatology
Apr 4, 2022
Functional Mitral Regurgitation Trial in Kunming (moderate-severe or greater (MR = 3+) functional mitral regurgitation (FMR)
Enrolling by invitation
- Functional Mitral Regurgitation
- moderate-severe or greater (MR ≥ 3+) functional mitral regurgitation (FMR) patients
-
Kunming, Yunnan, ChinaYunnan Fuwai Cardiovascular Hospital
Jul 2, 2023
Cardiogenic Shock Trial in Fuzhou (Impella)
Recruiting
- Cardiogenic Shock
- Impella
-
Fuzhou, Fujian, China
- +1 more
Nov 8, 2023
Glioma Trial (Paraffin pathological diagnosis)
Not yet recruiting
- Glioma
- Paraffin pathological diagnosis
- (no location specified)
Jun 4, 2023
Work-break Schedules Trial in Tübingen (Work break schedule)
Completed
- Work-break Schedules
- Work break schedule
-
Tübingen, Baden-Württemberg, GermanyInstitute of Occupational and Social Medicine and Health Service
Aug 26, 2021
Degenerative Mitral Valve Disease, Mitral Valve Regurgitation Trial (JensClip transcatheter valve repair system)
Not yet recruiting
- Degenerative Mitral Valve Disease
- Mitral Valve Regurgitation
- JensClip transcatheter valve repair system
- (no location specified)
Jun 9, 2022
Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC
Enrolling by invitation
- Primary Biliary Cholangitis
- Obeticholic Acid 5 MG
- +2 more
-
San Diego, CaliforniaIntercept Pharmaceuticals, Inc
Dec 15, 2022
Anesthesia Awareness Trial in Hradec Kralove (Group TCI, Group TIVA)
Recruiting
- Anesthesia Awareness
- Group TCI
- Group TIVA
-
Hradec Kralove, CzechiaUniversity Hospital Hradec Kralove
Feb 14, 2022
Percutaneous Coronary Intervention, Coronary Heart Disease, Robotic Surgical Procedures Trial (ALLVAS® robotic-assisted PCI)
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- ALLVAS® robotic-assisted PCI
- (no location specified)
Dec 7, 2022
Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC
Completed
- Primary Biliary Cholangitis
- Obeticholic Acid 5 MG
- +2 more
-
San Diego, CaliforniaIntercept Pharmaceuticals, Inc
Jul 30, 2022
Left Heart Failure Trial in Nantong (Atrial shunt implant system)
Recruiting
- Left Heart Failure
- Atrial shunt implant system
-
Nantong, Jiangsu, ChinaAtrial shunt implant system
Aug 1, 2022
DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma
Completed
- Localized Osteosarcoma
- +2 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Mar 11, 2022